Alcanna is spinning off its retail cannabis business and combining it with competing retailer YSS Corp. to create one of the largest networks of recreational marijuana stores in Canada, the companies announced Monday. The deal is the latest in a series of M&As in...
Matt Lamers
Matt Lamers's Latest Posts
More layoffs at Aurora Cannabis following Great North deal
Aurora Cannabis laid off sales staff after choosing Great North Distributors to be its sales representative across the Canadian recreational marijuana retail environment. Aurora was unable to share the specific number of employees who will be displaced as a result of...
GW Pharma expects fiscal 2020 sales to reach $526 million
United Kingdom-based GW Pharmaceuticals expects to report annual sales of roughly $526 million for the year ended Dec. 31, 2020, the company said in a preview of its fourth-quarter and full-year results. Fourth-quarter net sales will be...
Cannabis CEOs, led by Aphria’s Irwin Simon, are among Canada’s top-paid execs despite losses
A number of executives in the cannabis industry are among the highest-compensated CEOs in Canada, according to a new analysis of 2019 pay by the Ottawa think tank Centre for Policy Alternatives.
Mexico releases long-awaited medical cannabis regulations
Mexico published highly anticipated regulations to underpin its medical cannabis industry, more than three years after an amendment to the General Health Law allowed medical cannabis use. The long delay underscores a benefit of approaching...
Organigram revenue stalls on erratic inventory, unfulfilled demand
New Brunswick-based cannabis producer Organigram continues to struggle, reporting lower sales and a bigger loss for its first quarter ended Nov. 30, 2020. Net revenue for the three-month period fell to 19.3 million Canadian dollars ($15 million), lower than the...
How to arrive at an appropriate royalty fee when white labeling cannabis products
Third-party production, or white-label manufacturing of consumer products, is a method of combining valuable brands and production capabilities. Cannabis products are no different.
CEO compensation at marijuana producer Hexo rises to CA$11 million
Total compensation for the top executives at struggling marijuana producer Hexo Corp. grew almost 20% year-over-year to 14.4 million Canadian dollars ($11.1 million) in fiscal 2020, led by the company’s CEO, according to a financial disclosure filed with the U.S. Securities and Exchange Commission last month.
Aurora Cannabis co-founder Terry Booth tapped to be CEO of US-based Australis
Eleven months after stepping down as CEO of the Canadian marijuana giant he co-founded, former Aurora Cannabis chief executive Terry Booth said he plans to return to the marijuana industry to head up a U.S.-based cannabis investment firm that is an Aurora spinoff....
Ontario missing small amount of legal cannabis; vetting consultants extended
A small amount of legal recreational cannabis products in Ontario have gone unaccounted for, according to the provincial regulator responsible for adult use in Canada's largest market. Roughly 1,428 units of cannabis products were "lost or...
Canopy, Aphria cited for ‘critical’ cannabis regulatory breaches in 2018, new Health Canada report shows
Canadian cannabis giants Canopy Growth and Aphria were among a half-dozen licensed producers cited for serious regulatory violations in Health Canada’s compliance report covering the 2018-19 fiscal year.
Medical cannabis registrations surge in Canada amid pandemic
The number of active medical cannabis registrations in Canada grew at the fastest pace in nearly three years during the latest quarter, defying predictions that the medical sector would fizzle after adult-use prohibition came to an end. Canada added 73,803 active...












